Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

 14.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 17.50p
  • 52 Week Low: 2.95p
  • Currency: UK Pounds
  • Shares Issued: 113.66m
  • Volume: 1,144,780
  • Market Cap: £16.76m
  • RiskGrade: 464
  • Beta: 0.02

Newspaper Links

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

FAB Market Data

Currency UK Pounds
Share Price 14.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 17.50p
52 Week Low 2.95p
Volume 1,144,780
Shares Issued 113.66m
Market Cap £16.76m
Beta 0.02
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.52% below the market average55.52% below the market average55.52% below the market average55.52% below the market average55.52% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average
Price Trend
96.67% above the market average96.67% above the market average96.67% above the market average96.67% above the market average96.67% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
26.15% below the market average26.15% below the market average26.15% below the market average26.15% below the market average26.15% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

FAB Dividends

No dividends found

Trades for 28-Aug-2025

Time Volume / Share Price
16:29 8 @ 14.90p
16:27 2 @ 14.90p
15:10 70,000 @ 15.30p
16:10 10,000 @ 14.51p
16:06 10 @ 15.00p

FAB Key Personnel

Chair Simon Gordon Douglas
CEO Adrian Kinkaid

Top of Page